相关实验视频
Updated: Sep 11, 2025

06:33
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
7.8K
在肺患者中,α-1抗素基因型分布
Levent Özdemir1, Savaş Gegin2, Burcu Özdemir2
1Department of Chest Diseases, Samsun University Faculty of Medicine, Samsun, Turkey.
International journal of chronic obstructive pulmonary disease
|August 18, 2025
概括
阿尔法-1抗素缺乏症 (AATD) 影响4%的肺气患者,泛性肺气更为常见. 早期AATD基因型分析有助于通过增强疗法诊断和治疗.
科学领域:
- 肺部病理学 肺部病理学
- 遗传学 是一个遗传学.
- 罕见疾病 罕见疾病
背景情况:
- 阿尔法-1抗素缺乏症 (AATD) 是一种遗传性疾病,导致阿尔法-1抗素 (AAT) 水平较低.
- AATD是肺气的已知危险因素,这是一个严重的肺部疾病.
研究的目的:
- 为了确定肺气患者AATD的频率.
- 分析基于肺瘤类型和位置的AATD基因型分布.
- 评估AATD患者是否有资格接受增强疗法.
主要方法:
- 一项对794名肺瘤患者的横截面研究,使用高分辨率计算机断层扫描 (HRCT).
- 收集人口统计数据,吸烟状况,肺瘤类型/位置,并通过干燥的血液斑点进行AAT基因定型.
- 在被诊断为AATD的患者中评估AAT水平和肺功能测试 (PFT).
主要成果:
- 在4% (31/794) 的患者中发现了AATD突变;96%没有突变.
- AATD在泛性肺气中更为普遍.
- 常见的突变包括PI*M/M马尔顿,PI*M/Z,PI*M/I和PI*M马尔顿/M马尔顿. 在PI*Z/Z,PI*M马尔顿/M马尔顿和PI*Z/M马尔顿基因型中观察到低AAT水平. 六名患者接受了增强疗法.
结论:
- 在肺瘤患者中分析AAT基因型有助于早期诊断AATD.
- 早期诊断可以迅速实施预防策略和增强疗法.
- 基因定型有助于个性化管理AATD患者的肺气.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
COPD: Pathogenesis and Clinical Features
517
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
517
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K

